Identification of the Immunodominant Epitope Region in Phospholipase A2 Receptor-Mediating Autoantibody Binding in Idiopathic Membranous Nephropathy
Open Access
- 1 February 2015
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American Society of Nephrology
- Vol. 26 (2), 291-301
- https://doi.org/10.1681/asn.2013121315
Abstract
Membranous nephropathy (MN) is a common cause of nephrotic syndrome in adults. Recent clinical studies established that >70% of patients with idiopathic (also called primary) MN (IMN) possess circulating autoantibodies targeting the M-type phospholipase A2 receptor-1 (PLA2R) on the surface of glomerular visceral epithelial cells (podocytes). In situ, these autoantibodies trigger the formation of immune complexes, which are hypothesized to cause enhanced glomerular permeability to plasma proteins. Indeed, the level of autoantibody in circulation correlates with the severity of proteinuria in patients. The autoantibody only recognizes the nonreduced form of PLA2R, suggesting that disulfide bonds determine the antigenic epitope conformation. Here, we identified the immunodominant epitope region in PLA2R by probing isolated truncated PLA2R extracellular domains with sera from patients with IMN that contain anti-PLA2R autoantibodies. Patient sera specifically recognized a protein complex consisting of the cysteine-rich (CysR), fibronectin-like type II (FnII), and C-type lectin-like domain 1 (CTLD1) domains of PLA2R only under nonreducing conditions. Moreover, absence of either the CysR or CTLD1 domain prevented autoantibody recognition of the remaining domains. Additional analysis suggested that this three-domain complex contains at least one disulfide bond required for conformational configuration and autoantibody binding. Notably, the three-domain complex completely blocked the reactivity of autoantibodies from patient sera with the full-length PLA2R, and the reactivity of patient sera with the three-domain complex on immunoblots equaled the reactivity with full-length PLA2R. These results indicate that the immunodominant epitope in PLA2R is exclusively located in the CysR-FnII-CTLD1 region.Keywords
This publication has 27 references indexed in Scilit:
- Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathyKidney International, 2013
- Phospholipase A2 Receptor (PLA2R1) Sequence Variants in Idiopathic Membranous NephropathyJournal of the American Society of Nephrology, 2013
- Genetic Variants in Membranous NephropathyJournal of the American Society of Nephrology, 2013
- The pathogenesis of membranous nephropathyCurrent Opinion in Nephrology and Hypertension, 2012
- Idiopathic Membranous Nephropathy: An Autoimmune DiseaseSeminars in Nephrology, 2011
- Experimental models of membranous nephropathyDrug Discovery Today: Disease Models, 2010
- Membranous nephropathy: recent travels and new roads aheadKidney International, 2010
- M-Type Phospholipase A2Receptor as Target Antigen in Idiopathic Membranous NephropathyNew England Journal of Medicine, 2009
- The mannose receptor familyBiochimica et Biophysica Acta (BBA) - General Subjects, 2002
- Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis ratsThe Journal of Experimental Medicine, 1983